Becton Dickinson and Co
Change company Symbol lookup
Select an option...
BDX Becton Dickinson and Co
GGN GAMCO Global Gold, Natural Resources & Income Trust
GUT Gabelli Utility Trust
CHD Church & Dwight Co Inc
CHY Calamos Convertible & High Income Fund
CHW Calamos Global Dynamic Income Fund
CCVIX Calamos Convertible Fund Class A
ETY Eaton Vance Tax-Managed Diversified Equity Income Fund
ETB Eaton Vance Tax-Managed Buy-Write Income Fund
NEE Nextera Energy Inc
Go

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Closing Price
$241.15
Day's Change
-6.00 (-2.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
247.50
Day's Low
241.01
Volume
(Above Average)
Volume:
1,540,891

10-day average volume:
1,361,894
1,540,891

Soros laments investment in Palantir and says he will sell the rest when allowed

4:35 am ET November 18, 2020 (MarketWatch)
Print

By Steve Goldstein

It's common for fund managers to talk up their investments. Legendary investor George Soros is taking the opposite tack.

His family office, Soros Fund Management, issued a statement criticizing one of its holdings, Palantir Technologies (PLTR), after a Securities and Exchange Commission filing revealed it had a roughly 1% stake in the data analytics company.

That's a statement issued on Soros's Open Society website (https://www.opensocietyfoundations.org/newsroom/statement-from-soros-fund-management-on-palantir-investment). The statement went on to explain that the investment was made by a portfolio manager at the firm in 2012 when Palantir was private. When Palantir went public, Soros's investment was converted into shares in the public company.

"SFM has sold all shares in the company that it is not legally or contractually obliged to hold and will continue to sell shares as permitted," the statement added.

Palantir has drawn criticism for the work it has done for the U.S. government, notably the U.S. Immigration and Customs Enforcement agency.

Investors have warmed to the company, as its stock has nearly doubled in its short history as a public company.

Soros Fund Management, now a family office, has roughly $4 billion in assets under management.

-Steve Goldstein; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

November 18, 2020 04:35 ET (09:35 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.